BCA
Bay Colony Advisors’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-25,526
| Closed | -$250K | – | 429 |
|
|
2023
Q4 | $250K | Sell |
25,526
-700
| -3% | -$6.87K | 0.05% | 303 |
|
|
2023
Q3 | $219K | Sell |
26,226
-1,325
| -5% | -$11.1K | 0.05% | 297 |
|
|
2023
Q2 | $366K | Sell |
27,551
-4,500
| -14% | -$59.9K | 0.09% | 205 |
|
|
2023
Q1 | $313K | Buy |
32,051
+1,250
| +4% | +$12.2K | 0.08% | 223 |
|
|
2022
Q4 | $252K | Buy |
30,801
+1,250
| +4% | +$10.2K | 0.07% | 282 |
|
|
2022
Q3 | $172K | Buy |
29,551
+12,450
| +73% | +$72.5K | 0.05% | 300 |
|
|
2022
Q2 | $75K | Buy |
17,101
+2,347
| +16% | +$10.3K | 0.02% | 337 |
|
|
2022
Q1 | $134K | Buy |
14,754
+101
| +0.7% | +$917 | 0.03% | 347 |
|
|
2021
Q4 | $300K | Buy |
14,653
+150
| +1% | +$3.07K | 0.09% | 266 |
|
|
2021
Q3 | $371K | Buy |
14,503
+1,775
| +14% | +$45.4K | 0.12% | 204 |
|
|
2021
Q2 | $445K | Buy |
12,728
+825
| +7% | +$28.8K | 0.15% | 184 |
|
|
2021
Q1 | $396K | Buy |
+11,903
| New | +$396K | 0.15% | 178 |
|